HU163947B - - Google Patents

Info

Publication number
HU163947B
HU163947B HUSU681A HUSU000681A HU163947B HU 163947 B HU163947 B HU 163947B HU SU681 A HUSU681 A HU SU681A HU SU000681 A HUSU000681 A HU SU000681A HU 163947 B HU163947 B HU 163947B
Authority
HU
Hungary
Application number
HUSU681A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU163947B publication Critical patent/HU163947B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUSU681A 1970-10-20 1971-10-18 HU163947B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8250970A 1970-10-20 1970-10-20

Publications (1)

Publication Number Publication Date
HU163947B true HU163947B (enExample) 1973-11-28

Family

ID=22171656

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSU681A HU163947B (enExample) 1970-10-20 1971-10-18

Country Status (7)

Country Link
US (1) US3725403A (enExample)
CA (1) CA995669A (enExample)
CH (1) CH539633A (enExample)
DE (1) DE2152282A1 (enExample)
FR (1) FR2111728B1 (enExample)
GB (1) GB1374283A (enExample)
HU (1) HU163947B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436395A (en) * 1973-12-13 1976-05-19 Ici Ltd Morpholine derivatives
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
DE3726759A1 (de) * 1987-08-12 1989-03-09 Hoechst Ag Benzothiazinon-oxide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung sowie zwischenprodukte zu ihrer herstellung
DK0429676T3 (enExample) * 1989-06-16 1997-03-10 Santen Pharmaceutical Co Ltd
US5696117A (en) * 1995-11-07 1997-12-09 Ortho Pharmaceutical Corporation Benzoxazine antimicrobial agents
HUP9800757A3 (en) * 1996-01-17 1998-08-28 Taiho Pharmaceutical Co Ltd Intimal thickening inhibitors containing oxyindole derivatives and pharmaceutical compositions containing them
US5707990A (en) * 1996-01-30 1998-01-13 Ortho Pharmaceutical Corporation 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
IL137656A0 (en) * 1998-03-31 2001-10-31 Warner Lambert Co Benzoxazinones/benzothiazinones as serine protease inhibitors
CA2452169A1 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
CA2452366A1 (en) * 2001-06-29 2003-01-16 Ab Science Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
EP1434991B1 (en) * 2001-06-29 2007-10-17 AB Science New potent, selective and non toxic c-kit inhibitors
EP1471907B1 (en) * 2001-06-29 2008-07-16 AB Science Use of c-kit inhibitors for treating autoimmune diseases
PT1401416E (pt) * 2001-06-29 2007-02-28 Ab Science Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
US7700610B2 (en) 2001-06-29 2010-04-20 Ab Science Use of tyrosine kinase inhibitors for treating allergic diseases
CA2460845A1 (en) * 2001-09-20 2003-03-27 Ab Science Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
JP2005507916A (ja) * 2001-09-20 2005-03-24 アブ サイエンス 細菌感染症を治療するための、強力で選択的かつ非毒性のc−kit阻害剤の使用方法
WO2003035050A2 (en) * 2001-09-20 2003-05-01 Ab Science Use of tyrosine kinase inhibitors for promoting hair growth
CA2477111A1 (en) * 2002-02-27 2003-09-04 Ab Science Use of tyrosine kinase inhibitors for treating cns disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166554A (en) * 1965-01-19 Certificate of correction
US3341519A (en) * 1965-04-28 1967-09-12 Squibb & Sons Inc Novel benzoxazines, benzothiazines, benzoxazepins and benzothiazepins

Also Published As

Publication number Publication date
US3725403A (en) 1973-04-03
CA995669A (en) 1976-08-24
DE2152282A1 (de) 1972-04-27
CH539633A (fr) 1973-07-31
FR2111728A1 (enExample) 1972-06-09
FR2111728B1 (enExample) 1975-08-01
GB1374283A (en) 1974-11-20

Similar Documents

Publication Publication Date Title
FR2111728B1 (enExample)
ATA96471A (enExample)
AU2044470A (enExample)
AU1716970A (enExample)
AU1517670A (enExample)
AU2017870A (enExample)
AU1336970A (enExample)
AR195465A1 (enExample)
AU1581370A (enExample)
AU1969370A (enExample)
AU1881070A (enExample)
AU1343870A (enExample)
AU1086670A (enExample)
AU2119370A (enExample)
AU1004470A (enExample)
AU1603270A (enExample)
AU1789870A (enExample)
AU1328670A (enExample)
AU2130770A (enExample)
AU1247570A (enExample)
AU1689770A (enExample)
AU1943370A (enExample)
AU1235770A (enExample)
AU1591370A (enExample)
AU1841070A (enExample)